1 Market Overview

1.1 Alternative to Antibiotics Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Alternative to Antibiotics Revenue by Type: 2019 Versus 2021 Versus 2028

1.2.2 Antimicrobial Proteins

1.2.3 Bacteriophages

1.2.4 Probiotics

1.2.5 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Alternative to Antibiotics Revenue by Application: 2019 Versus 2021 Versus 2028

1.3.2 Food & Beverage

1.3.3 Drugs

1.3.4 Dietary Supplements

1.4 Global Alternative to Antibiotics Market Size & Forecast

1.4.1 Global Alternative to Antibiotics Sales in Value (2016-2028))

1.4.2 Global Alternative to Antibiotics Sales in Volume (2016-2028)

1.4.3 Global Alternative to Antibiotics Price by Type (2016-2028) & (US$/Unit)

1.5 Global Alternative to Antibiotics Production Capacity Analysis

1.5.1 Global Alternative to Antibiotics Total Production Capacity (2016-2028)

1.5.2 Global Alternative to Antibiotics Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Alternative to Antibiotics Market Drivers

1.6.2 Alternative to Antibiotics Market Restraints

1.6.3 Alternative to Antibiotics Trends Analysis

2 Manufacturers Profiles

2.1 DSM

2.1.1 DSM Details

2.1.2 DSM Major Business

2.1.3 DSM Alternative to Antibiotics Product and Services

2.1.4 DSM Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 DuPont(Danisco)

2.2.1 DuPont(Danisco) Details

2.2.2 DuPont(Danisco) Major Business

2.2.3 DuPont(Danisco) Alternative to Antibiotics Product and Services

2.2.4 DuPont(Danisco) Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Chr. Hansen

2.3.1 Chr. Hansen Details

2.3.2 Chr. Hansen Major Business

2.3.3 Chr. Hansen Alternative to Antibiotics Product and Services

2.3.4 Chr. Hansen Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Lallemand

2.4.1 Lallemand Details

2.4.2 Lallemand Major Business

2.4.3 Lallemand Alternative to Antibiotics Product and Services

2.4.4 Lallemand Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 China-Biotics

2.5.1 China-Biotics Details

2.5.2 China-Biotics Major Business

2.5.3 China-Biotics Alternative to Antibiotics Product and Services

2.5.4 China-Biotics Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Nestle

2.6.1 Nestle Details

2.6.2 Nestle Major Business

2.6.3 Nestle Alternative to Antibiotics Product and Services

2.6.4 Nestle Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Danone

2.7.1 Danone Details

2.7.2 Danone Major Business

2.7.3 Danone Alternative to Antibiotics Product and Services

2.7.4 Danone Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Probi

2.8.1 Probi Details

2.8.2 Probi Major Business

2.8.3 Probi Alternative to Antibiotics Product and Services

2.8.4 Probi Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 BioGaia

2.9.1 BioGaia Details

2.9.2 BioGaia Major Business

2.9.3 BioGaia Alternative to Antibiotics Product and Services

2.9.4 BioGaia Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Yakult

2.10.1 Yakult Details

2.10.2 Yakult Major Business

2.10.3 Yakult Alternative to Antibiotics Product and Services

2.10.4 Yakult Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Novozymes

2.11.1 Novozymes Details

2.11.2 Novozymes Major Business

2.11.3 Novozymes Alternative to Antibiotics Product and Services

2.11.4 Novozymes Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Valio

2.12.1 Valio Details

2.12.2 Valio Major Business

2.12.3 Valio Alternative to Antibiotics Product and Services

2.12.4 Valio Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Glory Biotech

2.13.1 Glory Biotech Details

2.13.2 Glory Biotech Major Business

2.13.3 Glory Biotech Alternative to Antibiotics Product and Services

2.13.4 Glory Biotech Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Ganeden

2.14.1 Ganeden Details

2.14.2 Ganeden Major Business

2.14.3 Ganeden Alternative to Antibiotics Product and Services

2.14.4 Ganeden Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Morinaga Milk Industry

2.15.1 Morinaga Milk Industry Details

2.15.2 Morinaga Milk Industry Major Business

2.15.3 Morinaga Milk Industry Alternative to Antibiotics Product and Services

2.15.4 Morinaga Milk Industry Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Sabinsa

2.16.1 Sabinsa Details

2.16.2 Sabinsa Major Business

2.16.3 Sabinsa Alternative to Antibiotics Product and Services

2.16.4 Sabinsa Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Greentech

2.17.1 Greentech Details

2.17.2 Greentech Major Business

2.17.3 Greentech Alternative to Antibiotics Product and Services

2.17.4 Greentech Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.18 Bioriginal

2.18.1 Bioriginal Details

2.18.2 Bioriginal Major Business

2.18.3 Bioriginal Alternative to Antibiotics Product and Services

2.18.4 Bioriginal Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.19 Biosearch Life

2.19.1 Biosearch Life Details

2.19.2 Biosearch Life Major Business

2.19.3 Biosearch Life Alternative to Antibiotics Product and Services

2.19.4 Biosearch Life Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.20 UAS Laboratories

2.20.1 UAS Laboratories Details

2.20.2 UAS Laboratories Major Business

2.20.3 UAS Laboratories Alternative to Antibiotics Product and Services

2.20.4 UAS Laboratories Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.21 Synbiotech

2.21.1 Synbiotech Details

2.21.2 Synbiotech Major Business

2.21.3 Synbiotech Alternative to Antibiotics Product and Services

2.21.4 Synbiotech Alternative to Antibiotics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Alternative to Antibiotics Sales by Manufacturer

3.1 Global Alternative to Antibiotics Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Alternative to Antibiotics Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Alternative to Antibiotics

3.4 Market Concentration Rate

3.4.1 Top 3 Alternative to Antibiotics Manufacturer Market Share

3.4.2 Top 6 Alternative to Antibiotics Manufacturer Market Share

3.5 Global Alternative to Antibiotics Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Alternative to Antibiotics Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Alternative to Antibiotics Market Size by Region

4.1.1 Global Alternative to Antibiotics Sales in Volume by Region (2016-2028)

4.1.2 Global Alternative to Antibiotics Revenue by Region (2016-2028)

4.2 North America Alternative to Antibiotics Revenue (2016-2028)

4.3 Europe Alternative to Antibiotics Revenue (2016-2028)

4.4 Asia-Pacific Alternative to Antibiotics Revenue (2016-2028)

4.5 South America Alternative to Antibiotics Revenue (2016-2028)

4.6 Middle East and Africa Alternative to Antibiotics Revenue (2016-2028)

5 Market Segment by Type

5.1 Global Alternative to Antibiotics Sales in Volume by Type (2016-2028)

5.2 Global Alternative to Antibiotics Revenue by Type (2016-2028)

5.3 Global Alternative to Antibiotics Price by Type (2016-2028)

6 Market Segment by Application

6.1 Global Alternative to Antibiotics Sales in Volume by Application (2016-2028)

6.2 Global Alternative to Antibiotics Revenue by Application (2016-2028)

6.3 Global Alternative to Antibiotics Price by Application (2016-2028)

7 North America by Country, by Type, and by Application

7.1 North America Alternative to Antibiotics Sales by Type (2016-2028)

7.2 North America Alternative to Antibiotics Sales by Application (2016-2028)

7.3 North America Alternative to Antibiotics Market Size by Country

7.3.1 North America Alternative to Antibiotics Sales in Volume by Country (2016-2028)

7.3.2 North America Alternative to Antibiotics Revenue by Country (2016-2028)

7.3.3 United States Market Size and Forecast (2016-2028)

7.3.4 Canada Market Size and Forecast (2016-2028)

7.3.5 Mexico Market Size and Forecast (2016-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Alternative to Antibiotics Sales by Type (2016-2028)

8.2 Europe Alternative to Antibiotics Sales by Application (2016-2028)

8.3 Europe Alternative to Antibiotics Market Size by Country

8.3.1 Europe Alternative to Antibiotics Sales in Volume by Country (2016-2028)

8.3.2 Europe Alternative to Antibiotics Revenue by Country (2016-2028)

8.3.3 Germany Market Size and Forecast (2016-2028)

8.3.4 France Market Size and Forecast (2016-2028)

8.3.5 United Kingdom Market Size and Forecast (2016-2028)

8.3.6 Russia Market Size and Forecast (2016-2028)

8.3.7 Italy Market Size and Forecast (2016-2028)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Alternative to Antibiotics Sales by Type (2016-2028)

9.2 Asia-Pacific Alternative to Antibiotics Sales by Application (2016-2028)

9.3 Asia-Pacific Alternative to Antibiotics Market Size by Region

9.3.1 Asia-Pacific Alternative to Antibiotics Sales in Volume by Region (2016-2028)

9.3.2 Asia-Pacific Alternative to Antibiotics Revenue by Region (2016-2028)

9.3.3 China Market Size and Forecast (2016-2028)

9.3.4 Japan Market Size and Forecast (2016-2028)

9.3.5 Korea Market Size and Forecast (2016-2028)

9.3.6 India Market Size and Forecast (2016-2028)

9.3.7 Southeast Asia Market Size and Forecast (2016-2028)

9.3.8 Australia Market Size and Forecast (2016-2028)

10 South America by Country, by Type, and by Application

10.1 South America Alternative to Antibiotics Sales by Type (2016-2028)

10.2 South America Alternative to Antibiotics Sales by Application (2016-2028)

10.3 South America Alternative to Antibiotics Market Size by Country

10.3.1 South America Alternative to Antibiotics Sales in Volume by Country (2016-2028)

10.3.2 South America Alternative to Antibiotics Revenue by Country (2016-2028)

10.3.3 Brazil Market Size and Forecast (2016-2028)

10.3.4 Argentina Market Size and Forecast (2016-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Alternative to Antibiotics Sales by Type (2016-2028)

11.2 Middle East & Africa Alternative to Antibiotics Sales by Application (2016-2028)

11.3 Middle East & Africa Alternative to Antibiotics Market Size by Country

11.3.1 Middle East & Africa Alternative to Antibiotics Sales in Volume by Country (2016-2028)

11.3.2 Middle East & Africa Alternative to Antibiotics Revenue by Country (2016-2028)

11.3.3 Turkey Market Size and Forecast (2016-2028)

11.3.4 Egypt Market Size and Forecast (2016-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2028)

11.3.6 South Africa Market Size and Forecast (2016-2028)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Alternative to Antibiotics Typical Distributors

12.3 Alternative to Antibiotics Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Alternative to Antibiotics Revenue by Type, (USD Million), 2021-2026

Table 2. Global Alternative to Antibiotics Revenue by Application, (USD Million), 2021-2026

Table 3. DSM Basic Information, Manufacturing Base and Competitors

Table 4. DSM Major Business

Table 5. DSM Alternative to Antibiotics Product and Services

Table 6. DSM Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. DuPont(Danisco) Basic Information, Manufacturing Base and Competitors

Table 8. DuPont(Danisco) Major Business

Table 9. DuPont(Danisco) Alternative to Antibiotics Product and Services

Table 10. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Chr. Hansen Basic Information, Manufacturing Base and Competitors

Table 12. Chr. Hansen Major Business

Table 13. Chr. Hansen Alternative to Antibiotics Product and Services

Table 14. Chr. Hansen Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Lallemand Basic Information, Manufacturing Base and Competitors

Table 16. Lallemand Major Business

Table 17. Lallemand Alternative to Antibiotics Product and Services

Table 18. Lallemand Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. China-Biotics Basic Information, Manufacturing Base and Competitors

Table 20. China-Biotics Major Business

Table 21. China-Biotics Alternative to Antibiotics Product and Services

Table 22. China-Biotics Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Nestle Basic Information, Manufacturing Base and Competitors

Table 24. Nestle Major Business

Table 25. Nestle Alternative to Antibiotics Product and Services

Table 26. Nestle Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Danone Basic Information, Manufacturing Base and Competitors

Table 28. Danone Major Business

Table 29. Danone Alternative to Antibiotics Product and Services

Table 30. Danone Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Probi Basic Information, Manufacturing Base and Competitors

Table 32. Probi Major Business

Table 33. Probi Alternative to Antibiotics Product and Services

Table 34. Probi Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. BioGaia Basic Information, Manufacturing Base and Competitors

Table 36. BioGaia Major Business

Table 37. BioGaia Alternative to Antibiotics Product and Services

Table 38. BioGaia Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Yakult Basic Information, Manufacturing Base and Competitors

Table 40. Yakult Major Business

Table 41. Yakult Alternative to Antibiotics Product and Services

Table 42. Yakult Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Novozymes Basic Information, Manufacturing Base and Competitors

Table 44. Novozymes Major Business

Table 45. Novozymes Alternative to Antibiotics Product and Services

Table 46. Novozymes Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Valio Basic Information, Manufacturing Base and Competitors

Table 48. Valio Major Business

Table 49. Valio Alternative to Antibiotics Product and Services

Table 50. Valio Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Glory Biotech Basic Information, Manufacturing Base and Competitors

Table 52. Glory Biotech Major Business

Table 53. Glory Biotech Alternative to Antibiotics Product and Services

Table 54. Glory Biotech Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Ganeden Basic Information, Manufacturing Base and Competitors

Table 56. Ganeden Major Business

Table 57. Ganeden Alternative to Antibiotics Product and Services

Table 58. Ganeden Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Morinaga Milk Industry Basic Information, Manufacturing Base and Competitors

Table 60. Morinaga Milk Industry Major Business

Table 61. Morinaga Milk Industry Alternative to Antibiotics Product and Services

Table 62. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Sabinsa Basic Information, Manufacturing Base and Competitors

Table 64. Sabinsa Major Business

Table 65. Sabinsa Alternative to Antibiotics Product and Services

Table 66. Sabinsa Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Greentech Basic Information, Manufacturing Base and Competitors

Table 68. Greentech Major Business

Table 69. Greentech Alternative to Antibiotics Product and Services

Table 70. Greentech Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. Bioriginal Basic Information, Manufacturing Base and Competitors

Table 72. Bioriginal Major Business

Table 73. Bioriginal Alternative to Antibiotics Product and Services

Table 74. Bioriginal Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 75. Biosearch Life Basic Information, Manufacturing Base and Competitors

Table 76. Biosearch Life Major Business

Table 77. Biosearch Life Alternative to Antibiotics Product and Services

Table 78. Biosearch Life Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 79. UAS Laboratories Basic Information, Manufacturing Base and Competitors

Table 80. UAS Laboratories Major Business

Table 81. UAS Laboratories Alternative to Antibiotics Product and Services

Table 82. UAS Laboratories Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 83. Synbiotech Basic Information, Manufacturing Base and Competitors

Table 84. Synbiotech Major Business

Table 85. Synbiotech Alternative to Antibiotics Product and Services

Table 86. Synbiotech Alternative to Antibiotics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 87. Global Alternative to Antibiotics Sales by Manufacturer (2019-2021e) & (K Units)

Table 88. Global Alternative to Antibiotics Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 89. Market Position of Manufacturers in Alternative to Antibiotics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 90. Global Alternative to Antibiotics Production Capacity by Company, (K Units): 2020 VS 2021

Table 91. Head Office and Alternative to Antibiotics Production Site of Key Manufacturer

Table 92. Alternative to Antibiotics New Entrant and Capacity Expansion Plans

Table 93. Alternative to Antibiotics Mergers & Acquisitions in the Past Five Years

Table 94. Global Alternative to Antibiotics Sales by Region (2016-2021e) & (K Units)

Table 95. Global Alternative to Antibiotics Sales by Region (2021-2026) & (K Units)

Table 96. Global Alternative to Antibiotics Revenue by Region (2016-2021e) & (USD Million)

Table 97. Global Alternative to Antibiotics Revenue by Region (2021-2026) & (USD Million)

Table 98. Global Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 99. Global Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 100. Global Alternative to Antibiotics Revenue by Type (2016-2021e) & (USD Million)

Table 101. Global Alternative to Antibiotics Revenue by Type (2021-2026) & (USD Million)

Table 102. Global Alternative to Antibiotics Price by Type (2016-2021e) & (US$/Unit)

Table 103. Global Alternative to Antibiotics Price by Type (2021-2026) & (US$/Unit)

Table 104. Global Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 105. Global Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 106. Global Alternative to Antibiotics Revenue by Application (2016-2021e) & (USD Million)

Table 107. Global Alternative to Antibiotics Revenue by Application (2021-2026) & (USD Million)

Table 108. Global Alternative to Antibiotics Price by Application (2016-2021e) & (US$/Unit)

Table 109. Global Alternative to Antibiotics Price by Application (2021-2026) & (US$/Unit)

Table 110. North America Alternative to Antibiotics Sales by Country (2016-2021e) & (K Units)

Table 111. North America Alternative to Antibiotics Sales by Country (2021-2026) & (K Units)

Table 112. North America Alternative to Antibiotics Revenue by Country (2016-2021e) & (USD Million)

Table 113. North America Alternative to Antibiotics Revenue by Country (2021-2026) & (USD Million)

Table 114. North America Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 115. North America Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 116. North America Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 117. North America Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 118. Europe Alternative to Antibiotics Sales by Country (2016-2021e) & (K Units)

Table 119. Europe Alternative to Antibiotics Sales by Country (2021-2026) & (K Units)

Table 120. Europe Alternative to Antibiotics Revenue by Country (2016-2021e) & (USD Million)

Table 121. Europe Alternative to Antibiotics Revenue by Country (2021-2026) & (USD Million)

Table 122. Europe Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 123. Europe Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 124. Europe Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 125. Europe Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 126. Asia-Pacific Alternative to Antibiotics Sales by Region (2016-2021e) & (K Units)

Table 127. Asia-Pacific Alternative to Antibiotics Sales by Region (2021-2026) & (K Units)

Table 128. Asia-Pacific Alternative to Antibiotics Revenue by Region (2016-2021e) & (USD Million)

Table 129. Asia-Pacific Alternative to Antibiotics Revenue by Region (2021-2026) & (USD Million)

Table 130. Asia-Pacific Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 131. Asia-Pacific Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 132. Asia-Pacific Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 133. Asia-Pacific Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 134. South America Alternative to Antibiotics Sales by Country (2016-2021e) & (K Units)

Table 135. South America Alternative to Antibiotics Sales by Country (2021-2026) & (K Units)

Table 136. South America Alternative to Antibiotics Revenue by Country (2016-2021e) & (USD Million)

Table 137. South America Alternative to Antibiotics Revenue by Country (2021-2026) & (USD Million)

Table 138. South America Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 139. South America Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 140. South America Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 141. South America Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 142. Middle East & Africa Alternative to Antibiotics Sales by Country (2016-2021e) & (K Units)

Table 143. Middle East & Africa Alternative to Antibiotics Sales by Country (2021-2026) & (K Units)

Table 144. Middle East & Africa Alternative to Antibiotics Revenue by Country (2016-2021e) & (USD Million)

Table 145. Middle East & Africa Alternative to Antibiotics Revenue by Country (2021-2026) & (USD Million)

Table 146. Middle East & Africa Alternative to Antibiotics Sales by Type (2016-2021e) & (K Units)

Table 147. Middle East & Africa Alternative to Antibiotics Sales by Type (2021-2026) & (K Units)

Table 148. Middle East & Africa Alternative to Antibiotics Sales by Application (2016-2021e) & (K Units)

Table 149. Middle East & Africa Alternative to Antibiotics Sales by Application (2021-2026) & (K Units)

Table 150. Direct Channel Pros & Cons

Table 151. Indirect Channel Pros & Cons

Table 152. Alternative to Antibiotics Typical Distributors

Table 153. Alternative to Antibiotics Typical Customers

List of Figures

Figure 1. Alternative to Antibiotics Picture

Figure 2. Global Alternative to Antibiotics Sales Market Share by Type in 2020

Figure 3. Antimicrobial Proteins

Figure 4. Bacteriophages

Figure 5. Probiotics

Figure 6. Other

Figure 7. Global Alternative to Antibiotics Sales Market Share by Application in 2020

Figure 8. Food & Beverage

Figure 9. Drugs

Figure 10. Dietary Supplements

Figure 11. Global Alternative to Antibiotics Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 12. Global Alternative to Antibiotics Market Size and Forecast (2016-2026) & (USD Million)

Figure 13. Global Alternative to Antibiotics Sales (2016-2026) & (K Units)

Figure 14. Global Alternative to Antibiotics Price by Type (2016-2026) & (US$/Unit)

Figure 15. Global Alternative to Antibiotics Production Capacity (2016-2026) & (K Units)

Figure 16. Global Alternative to Antibiotics Production Capacity by Geographic Region: 2020 VS 2021

Figure 17. Alternative to Antibiotics Market Drivers

Figure 18. Alternative to Antibiotics Market Restraints

Figure 19. Alternative to Antibiotics Market Trends

Figure 20. Global Alternative to Antibiotics Sales Market Share by Manufacturer in 2020

Figure 21. Global Alternative to Antibiotics Revenue Market Share by Manufacturer in 2020

Figure 22. Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. Top 3 Alternative to Antibiotics Manufacturer (Revenue) Market Share in 2020

Figure 24. Top 6 Alternative to Antibiotics Manufacturer (Revenue) Market Share in 2020

Figure 25. Global Alternative to Antibiotics Sales Market Share by Region (2016-2026)

Figure 26. Global Alternative to Antibiotics Revenue Market Share by Region (2016-2026)

Figure 27. North America Alternative to Antibiotics Revenue (2016-2026) & (USD Million)

Figure 28. Europe Alternative to Antibiotics Revenue (2016-2026) & (USD Million)

Figure 29. Asia-Pacific Alternative to Antibiotics Revenue (2016-2026) & (USD Million)

Figure 30. South America Alternative to Antibiotics Revenue (2016-2026) & (USD Million)

Figure 31. Middle East & Africa Alternative to Antibiotics Revenue (2016-2026) & (USD Million)

Figure 32. Global Alternative to Antibiotics Sales Market Share by Type (2016-2026)

Figure 33. Global Alternative to Antibiotics Revenue Market Share by Type (2016-2026)

Figure 34. Global Alternative to Antibiotics Price by Type (2016-2026) & (US$/Unit)

Figure 35. Global Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 36. Global Alternative to Antibiotics Revenue Market Share by Application (2016-2026)

Figure 37. Global Alternative to Antibiotics Price by Application (2016-2026) & (US$/Unit)

Figure 38. North America Alternative to Antibiotics Sales Market Share by Type (2016-2026)

Figure 39. North America Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 40. North America Alternative to Antibiotics Sales Market Share by Country (2016-2026)

Figure 41. North America Alternative to Antibiotics Revenue Market Share by Country (2016-2026)

Figure 42. United States Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Alternative to Antibiotics Sales Market Share by Type (2016-2026)

Figure 46. Europe Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 47. Europe Alternative to Antibiotics Sales Market Share by Country (2016-2026)

Figure 48. Europe Alternative to Antibiotics Revenue Market Share by Country (2016-2026)

Figure 49. Germany Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Alternative to Antibiotics Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Alternative to Antibiotics Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific Alternative to Antibiotics Revenue Market Share by Region (2016-2026)

Figure 58. China Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Korea Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America Alternative to Antibiotics Sales Market Share by Type (2016-2026)

Figure 65. South America Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 66. South America Alternative to Antibiotics Sales Market Share by Country (2016-2026)

Figure 67. South America Alternative to Antibiotics Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East & Africa Alternative to Antibiotics Sales Market Share by Type (2016-2026)

Figure 71. Middle East & Africa Alternative to Antibiotics Sales Market Share by Application (2016-2026)

Figure 72. Middle East & Africa Alternative to Antibiotics Sales Market Share by Country (2016-2026)

Figure 73. Middle East & Africa Alternative to Antibiotics Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Egypt Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Africa Alternative to Antibiotics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source